A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy Adults · Healthy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States

Study leads

Pfizer CT.gov Call Center
Study Director
Pfizer

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin (Somatropin) Delivery and Taken up Into the Blood in Healthy Adults

Healthy

Abroad (travel likely)RecruitingPHASE1

Brussels, Belgium

Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration

Healthy · Active Non-segmental Vitiligo · Severe Alopecia Areata

Abroad (travel likely)RecruitingPHASE1

Shanghai, China

A Study to Evaluate the Safety of Increasing Doses of DF5112 in Healthy Adults

Healthy Participants · Healthy Adult Females · Healthy Adult Male

Abroad (travel likely)RecruitingPHASE1

Sydney, Australia

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects

Healthy

Abroad (travel likely)RecruitingPHASE1

Groningen, Netherlands